Skip to main content

Table 1 Sociodemographic and clinical characteristics of patients on operated for rheumatic mitral stenosis at JKCI from January 2020 to April 2021 (N = 54)

From: Health related quality of life of patients following mechanical valve replacement surgery for rheumatic mitral stenosis in Tanzania

Variable

Mean (±SD)/Frequency (%)

Gender (female)

34 (63)

Age of patients (years)

37.98 ± 12.78

Duration of symptoms, mean (years)

6.83 ± 5.51

Proportion residing outside of Dar Es Salaam

45 (83.3)

Proportion married

36 (66.7)

Proportion without health insurance

17 (31.5)

The proportion of low income

42 (77.8)

The proportion of primary education

35 (64.8)

Hypertensives

6 (11.1)

Patients with stroke

9 (16.7)

Patients with atrial fibrillation

24 (44.4)

Patients in heart failure NYHA class III-IV

15 (27.8)

Proportion on anticoagulants (preoperatively)

10 (18.5)

The proportion with pure MS

19 (35.2)

The proportion of pulmonary hypertension

45 (83.3)

The proportion with moderate-severe dilated LA

43 (79.6)

Mitral valve area, mean (cm2)

1.14 ± 0.39

Trans mitral pressure gradient, mean (mmHg)

12.54 ± 3.57

Proportion with elevated C-reactive protein

33 (61.1)

Proportion who underwent SVR

37 (68.5)

  1. Legend: NYHA = New York Heart Association, MS = Mitral stenosis, LVEF =.
  2. Left ventricular ejection fraction, TAPSE = Tricuspid Annular Plane Systolic Excursion.
  3. LA = left atrium, SVR = Single (mitral) valve replacement.